Your browser is no longer supported. Please, upgrade your browser.
Defiance Nasdaq Junior Biotechnology ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.28%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-4.18%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-6.43%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-15.08%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year0.45%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range26.78 - 41.45 Perf YTD-18.06%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-30.95% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low6.89% ATR0.45
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)46.91 Volatility0.76% 0.99%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.06 Prev Close28.22
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.43K Price28.62
Recom- SMA200.32% SMA50-3.39% SMA200-11.26% Volume1,591 Change1.42%
Oct-22-21 04:00PM  
Dec-29-20 01:50PM  
Nov-12-20 03:36PM  
Oct-05-20 01:23PM  
Oct-01-20 01:00PM  
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.